发明名称 RECOMBINANT PLASMID DNA pHILP07 ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN Lispro, CELL Escherichia coli TRANSFORMED BY RECOMBINANT PLASMID DNA pHILP07, AND STRAIN OF BACTERIA Escherichia coli JM109/pHILP07 - PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN Lispro
摘要 FIELD: biotechnology.SUBSTANCE: invention is a recombinant plasmid DNA pHILP07 directing the synthesis of the human hybrid protein with human proinsulin Lispro, containing the DNA encoding the human protein with human proinsulin Lispro with size of 134 amino-acid residue with the amino acid sequence, shown in Figure 2, comprising the amino acid sequences of the leader peptide in the form of the N-terminal fragment of human gamma-interferon connected to proinsulin Lispro by the peptide linker. Based on the recombinant plasmid pHILP07 the strain Escherichia coli JM109/pHILP07 is obtained, which is the producer of the human protein with proinsulin Lispro, registered in the federal state unitary enterprise State Research Institute of Genetics RNCIM under the number B-11410.EFFECT: invention enables to simplify the technology of isolation of insulin Lispro and to increase its output.4 cl, 2 dwg, 2 ex
申请公布号 RU2514480(C1) 申请公布日期 2014.04.27
申请号 RU20130119786 申请日期 2013.04.29
申请人 OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'JU "BIOKLONTEK" 发明人 SHMATCHENKO VADIM VASIL'EVICH
分类号 C12N15/00;C12N1/21;C12N15/17 主分类号 C12N15/00
代理机构 代理人
主权项
地址